Editas Medicine, Inc. (EDIT): Kevin Bitterman , director 10% owner of Editas Medicine, Inc. sold 500,000 shares on Sep 8, 2016. The Insider selling transaction was reported by the company on Sep 12, 2016 to the Securities and Exchange Commission. The shares were sold at $16.80 per share for a total value of $8,400,000.00 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on Sep 7, 2016, Kevin P Starr (10% owner) sold 5,890 shares at $15.90 per share price.On Aug 24, 2016, Alexandra Glucksmann (Chief Operating Officer) sold 1,000 shares at $20.00 per share price.
Company has been under the radar of several Street Analysts.Editas Medicine, Inc. is Upgraded by Jefferies to Buy. Earlier the firm had a rating of Hold on the company shares. The Rating was issued on Aug 10, 2016.